| URL | https://finance.yahoo.com/news/barda-exercises-fir |
| Source | Yahoo Finance |
| Date Published | 09/22/2022 |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Marinus Pharma |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2022 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 12.3 |
| City reshored to: | Radnor |
| State(s) reshored to: | PA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | ganaxolone API |
| What domestic positive factors made reshoring more attractive? | Government Incentives, BARDA, HHS |
| Government Incentive dollar amount: | $51 million |